Guest
Pandemic deputy chief medical officer moves to Moderna Sir Jonathan Van-Tam UK former deputy chief medical officer Senior Strategy Adviser in Medicine (Nottingham University) Now (as of 2nd May) a senior medical consultant to the Covid-19 vaccine maker Moderna. Was a member of the government vaccine taskforce during pandemic, Made decisions on 'all vaccine supply contracts and major investments in manufacturing and clinical opportunities'. UK government Britain bought 77,000,000 moderna vaccines Struck a 10-year £billion partnership with Modern to build a new factory Government has committed to buying Moderna’s vaccines for the next decade. JVT ‘advisory fee’, not disclosed Prohibited from using privileged information from his time in government to further his business interests Rose Whiffen, Transparency International UK 'Currently, there are only threadbare safeguards against abuse of the revolving door between the public and private sector.' Created a 'risk of privileged information being misused for commercial benefit'. Government Chief Scientific Adviser, April 2018 to April 2023 President, R&D at GlaxoSmithKline, 2012 to 2017 Had been Senior Vice President, Medicines Discovery and Development (joined the company in May 2006 as Head of Drug Discovery) He was a member of the GSK Board and the Corporate Executive Team. Total of pay and bonuses in 2017, £ 4,400,000 Sold most of his GSK bonus shares before joining the government (except £600,000) Chief science adviser pay was £185,000. Is the US squeaky clean?
